Secukinumab Provides Complete or Almost-Complete Psoriasis Clearance in Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of 4 Phase 3 Trials. (2018). SKIN The Journal of Cutaneous Medicine, 2(S1), S19. https://doi.org/10.25251/skin.2.supp.19